Nothing Special   »   [go: up one dir, main page]

Simonova et al., 2014 - Google Patents

A comprehensive ovine model of blood transfusion

Simonova et al., 2014

View PDF
Document ID
11085674092735819387
Author
Simonova G
Tung J
Fraser J
Do H
Staib A
Chew M
Dunster K
Glenister K
Jackson D
Fung Y
Publication year
Publication venue
Vox Sanguinis

External Links

Snippet

Background The growing awareness of transfusion‐associated morbidity and mortality necessitates investigations into the underlying mechanisms. Small animals have been the dominant transfusion model but have associated limitations. This study aimed to develop a …
Continue reading at core.ac.uk (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes

Similar Documents

Publication Publication Date Title
Simonova et al. A comprehensive ovine model of blood transfusion
Acker et al. A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing
Bianchi et al. Leucoreduction of blood components: an effective way to increase blood safety?
McMichael et al. Effect of leukoreduction on transfusion‐induced inflammation in dogs
Callan et al. Transfusion of 28‐day‐old leucoreduced or non‐leucoreduced stored red blood cells induces an inflammatory response in healthy dogs
Davidow et al. Association of veterinary hematology and transfusion medicine (AVHTM) transfusion reaction small animal consensus statement (TRACS) part 2: prevention and monitoring
Cancelas et al. Stored red blood cell viability is maintained after treatment with a second‐generation S‐303 pathogen inactivation process
Oikawa et al. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasma
Dholakia et al. Determination of RBC survival in C57BL/6 and C57BL/6-Tg (UBC–GFP) mice
Larsson et al. Non‐phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags
Lacerda et al. Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage
Serrano et al. An investigation of red blood cell concentrate quality during storage in paediatric‐sized polyvinylchloride bags plasticized with alternatives to di‐2‐ethylhexyl phthalate (DEHP)
Fung et al. Stored blood transfusion induces transient pulmonary arterial hypertension without impairing coagulation in an ovine model of nontraumatic haemorrhage
Winter et al. Understanding the effects of gamma‐irradiation on potassium levels in red cell concentrates stored in SAG‐M for neonatal red cell transfusion
Trakhtman et al. The pathogen‐reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases
Vetlesen et al. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system
Sut et al. Soluble CD40L and CD62P levels differ in single‐donor apheresis platelet concentrates and buffy coat–derived pooled platelet concentrates
Feige et al. Automated plasmapheresis compared with other plasma collection methods in the horse
Weisbach et al. The in vitro quality of washed, prestorage leucocyte‐depleted red blood cell concentrates
Radcliffe et al. Collection and administration of blood products in horses: Transfusion indications, materials, methods, complications, donor selection, and blood testing
Tynngård et al. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions
Helm et al. Blood transfusions in dogs and cats 1. Indications
Serrano et al. Supernatant reduction of stored gamma‐irradiated red blood cells minimizes potentially harmful substances present in transfusion aliquots for neonates
Slichter et al. Platelet concentrates prepared after a 20‐to 24‐hour hold of the whole blood at 22° C
Snyder et al. In vitro and in vivo evaluation of a whole blood platelet‐sparing leukoreduction filtration system